The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.
CommoditiesShare: BUY ETH Stage 1 (Conv: 2/5 | Size: 10%)
A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease. Source: Read the original article on www.nytimes.com